04.28.11
Applied Biology Company (ABC), the holding company of CIT Safety & Health Research Laboratories (CIT), has acquired the assets of LAB Research, Inc., consisting of three facilities located in Canada, Denmark and Hungary.
The newly created CIT-LAB group will have consolidated sales of $103 million and 830 staff across five sites in France (Evreux and Saint-Nazaire), Canada (Laval), Denmark (Lille Skensved) and Hungary (Veszprém). The financial details were not disclosed.
CIT has more than 40 years of experience providing preclinical contract research. The CIT-LAB group expands services in North America with LAB Research’s facilities in Canada. The Scandinavian and Central Europe facilities are also a key asset and will allow closer support for more customers.
“With the acquisition of Lab Research, we seized a major opportunity to create a global player serving the pharmaceutical, biotechnology and chemical industries. At a time when the biggest industry companies are turning to global outsourcing agreements, the new CIT-LAB group will be a partner of choice thanks to its ability to carry out a broader range of studies and to provide scientific synergies between facilities,” said Dr. Jean-François Le Bigot, CIT and ABC executive chairman.
The newly created CIT-LAB group will have consolidated sales of $103 million and 830 staff across five sites in France (Evreux and Saint-Nazaire), Canada (Laval), Denmark (Lille Skensved) and Hungary (Veszprém). The financial details were not disclosed.
CIT has more than 40 years of experience providing preclinical contract research. The CIT-LAB group expands services in North America with LAB Research’s facilities in Canada. The Scandinavian and Central Europe facilities are also a key asset and will allow closer support for more customers.
“With the acquisition of Lab Research, we seized a major opportunity to create a global player serving the pharmaceutical, biotechnology and chemical industries. At a time when the biggest industry companies are turning to global outsourcing agreements, the new CIT-LAB group will be a partner of choice thanks to its ability to carry out a broader range of studies and to provide scientific synergies between facilities,” said Dr. Jean-François Le Bigot, CIT and ABC executive chairman.
